Skip to Main Content

Paper Details

Three-year outcomes of the postapproval study of the AtriCure Bipolar Radiofrequency Ablation of Permanent Atrial Fibrillation Trial.
J Thorac Cardiovasc Surg
8
2022
Atrial Fibrillation, Congestive heart failure, Diabetes, Hypertension, Stroke, VAScular disease, Warfarin, atrial fibrillation, nonparoxysmal atrial fibrillation, patients
Author NameAffiliation
Marc W Gerdisch
Richard J SheminSchool of Medicine at university of california los angeles
Richard J SheminSchool of Medicine at university of california los angeles
  • 1 - 3

Datasets

Release 1.2